Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.42B |
| 2 |
Vale
VALE
|
+$1.05B |
| 3 |
Freeport-McMoran
FCX
|
+$988M |
| 4 |
Micron Technology
MU
|
+$690M |
| 5 |
ExxonMobil
XOM
|
+$534M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$2.21B |
| 2 |
TC Energy
TRP
|
+$1.37B |
| 3 |
Microsoft
MSFT
|
+$1.32B |
| 4 |
Verizon
VZ
|
+$1.31B |
| 5 |
Amazon
AMZN
|
+$940M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.11% |
| 2 | Technology | 16.54% |
| 3 | Communication Services | 12.92% |
| 4 | Consumer Discretionary | 12.55% |
| 5 | Industrials | 7.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AJRD
251
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $116M | 0.04% |
3,253,046
+1,063,046
| +49% | +$39.2M |
|
252
Tencent Music
TME
$14B
| $115M | 0.04% |
6,365,245
-773,742
| -11% | -$12.4M |
|
253
America Movil
AMX
$69.9B
| $113M | 0.04% |
7,947,650
-6,121
| -0.1% | -$92.4K |
|
254
Healthpeak Properties
DOC
$14.3B
| $112M | 0.04% |
+3,582,806
| New | +$109M |
|
|
VIAB
255
DELISTED
Viacom Inc. Class B
VIAB
| $112M | 0.04% |
3,981,549
-13,192,244
| -77% | -$379M |
|
256
CMS Energy
CMS
$22.1B
| $111M | 0.04% |
2,000,134
+30
| +0% | +$1.58K |
|
|
BLD
257
DELISTED
TopBuild
BLD
| $110M | 0.04% |
1,704,538
+654,538
| +62% | +$36.8M |
|
258
Fox Class A
FOXA
$27B
| $108M | 0.03% |
+2,935,408
| New | +$114M |
|
259
TechnipFMC
FTI
$29.7B
| $106M | 0.03% |
6,077,624
+214,667
| +4% | +$3.63M |
|
|
CZR
260
DELISTED
Caesars Entertainment Corporation
CZR
| $103M | 0.03% |
11,907,085
+362,802
| +3% | +$3.15M |
|
|
DCUD
261
DELISTED
Dominion Energy, Inc 2016 Series A Corporate Units
DCUD
| $103M | 0.03% |
2,055,646
+487
| +0% | +$23.7K |
|
|
ADSW
262
DELISTED
Advanced Disposal Services Inc
ADSW
| $102M | 0.03% |
3,644,503
-150,000
| -4% | -$3.9M |
|
263
Lumen
LUMN
$6.49B
| $101M | 0.03% |
8,434,584
+4,929,189
| +141% | +$68.5M |
|
264
D.R. Horton
DHI
$41.6B
| $101M | 0.03% |
2,442,000
-308,000
| -11% | -$12.1M |
|
265
Cedar Fair
FUN
$1.74B
| $97.1M | 0.03% |
1,846,000
-358,675
| -16% | -$19.1M |
|
266
Allogene Therapeutics
ALLO
$697M
| $95.7M | 0.03% |
3,350,532
+843,344
| +34% | +$24.5M |
|
267
Digital Realty Trust
DLR
$73.3B
| $94.9M | 0.03% |
797,403
+283,381
| +55% | +$31.6M |
|
268
Analog Devices
ADI
$188B
| $94.7M | 0.03% |
900,043
| – | – |
|
269
Curtiss-Wright
CW
$25.5B
| $92.8M | 0.03% |
818,484
+30,000
| +4% | +$3.42M |
|
|
NUAN
270
DELISTED
Nuance Communications, Inc.
NUAN
| $92.6M | 0.03% |
6,316,963
+4,471,814
| +242% | +$62M |
|
|
LOMA
271
Loma Negra
LOMA
$1.12B
| $91.6M | 0.03% |
8,366,500
+8,230,010
| +6,030% | +$98.1M |
|
272
Euronet Worldwide
EEFT
$2.7B
| $90.1M | 0.03% |
+632,200
| New | +$78.8M |
|
273
NMI Holdings
NMIH
$3.38B
| $90.1M | 0.03% |
3,481,202
| – | – |
|
|
JOYY
274
JOYY Inc
JOYY
$3.63B
| $89.6M | 0.03% |
1,066,000
| – | – |
|
275
LivaNova
LIVN
$4.47B
| $89.5M | 0.03% |
919,900
+636,300
| +224% | +$59.4M |
|
Similar funds
Capital Research Global Investors's Q1 2019 Portfolio in Review
As of Q1 2019, Capital Research Global Investors held 442 positions worth $315B, up 9.9% from $287B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Capital Research Global Investors's Q1 2019 filing shows 25 new, 151 increased, 166 reduced and 27 closed positions. Its largest new stake was Micron Technology: 17,867,672 shares worth $738M. The largest sale was AbbVie, an estimated $2.21B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 23% a quarter earlier, followed by Technology and Communication Services.
- Capital Research Global Investors's largest Q1 2019 buy was Micron Technology: 17,867,672 shares worth $738M.
- Capital Research Global Investors added most to Alibaba in Q1 2019, an estimated $1.42B increase.
- Capital Research Global Investors's biggest Q1 2019 reduction was AbbVie, cutting an estimated $2.21B.
- Capital Research Global Investors fully exited TC Energy in Q1 2019, selling an estimated $1.37B.
- Capital Research Global Investors's ten largest holdings make up 27% of its $315B portfolio in Q1 2019.
- Capital Research Global Investors opened 25 new positions and closed 27 in Q1 2019.
- Capital Research Global Investors's portfolio value rose 9.9% quarter-over-quarter to $315B.
Based on Capital Research Global Investors's 13F filing for Q1 2019, filed 15 May 2019.